Markets:

Overview

News

Currencies

International

Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

16.67 -0.09 (-0.54%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Theravance Biopharma, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

April 28, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

April 21, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm

April 02, 2026

From The Schall Law Firm

Via Business Wire

Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum ↗

February 11, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

What's going on in today's session ↗

March 03, 2026

Via Chartmill

These stocks are moving in today's session ↗

March 03, 2026

Via Chartmill

TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗

March 03, 2026

The company reported that its Phase 3 CYPRESS study of ampreloxetine in patients with hypotension failed to meet its primary endpoint.

Via Stocktwits

Topics Workforce

Which stocks are gapping on Tuesday? ↗

March 03, 2026

Via Chartmill

Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million ↗

February 23, 2026

This healthcare firm runs a national network of surgical centers, specializing in outpatient procedures across key medical specialties.

Via The Motley Fool

Topics Regulatory Compliance

Alkami Stock Down 50%, But This New $49 Million Stake Signals Conviction in a Turnaround ↗

February 23, 2026

This fintech firm provides cloud-based digital banking solutions for U.S. financial institutions with a focus on subscription revenue.

Via The Motley Fool

Topics Regulatory Compliance

Integer Holdings Lands New $99 Million Stake Even With Stock Down Over 30% This Past Year ↗

February 23, 2026

Integer Holdings delivers specialized medical devices and battery solutions to major healthcare OEMs worldwide.

Via The Motley Fool

Topics Regulatory Compliance

Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters ↗

February 23, 2026

This cloud-based supply chain software provider serves retailers and distributors with automation and analytics solutions.

Via The Motley Fool

Topics Economy Regulatory Compliance Supply Chain

Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗

February 22, 2026

Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.

Via The Motley Fool

Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗

February 22, 2026

Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.

Via The Motley Fool

Topics Regulatory Compliance

Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗

February 22, 2026

Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.

Via The Motley Fool

Topics Regulatory Compliance

Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗

February 22, 2026

Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.

Via The Motley Fool

Topics Regulatory Compliance

Irenic Dumps Most Papa John's Shares ↗

February 22, 2026

Papa John's International runs a global pizza network, earning revenue from both direct restaurant operations and franchise royalties.

Via The Motley Fool

Topics ETFs Regulatory Compliance

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 26, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Friday. ↗

January 23, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Tuesday. ↗

January 13, 2026

Via Chartmill

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗

December 07, 2025

A newly public real-estate platform is putting up numbers that look far more seasoned than its age.

Via The Motley Fool

Topics Regulatory Compliance

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗

December 07, 2025

One fund just made a bold bet on a telecom stock undergoing a big transformation

Via The Motley Fool

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗

December 07, 2025

This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.

Via The Motley Fool

Topics Regulatory Compliance

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗

December 07, 2025

A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.

Via The Motley Fool

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Here's Why Shares in Theravance Biopharma Exploded Today ↗

November 11, 2025

The company is making excellent progress on all its strategic goals.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 11, 2025

Via Benzinga

Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction ↗

November 10, 2025

Theravance Biopharma (TBPH) reported Q3 2025 results, beating EPS estimates with a profit of $0.04. Revenue was slightly below forecasts. Lead drug YUPELRI achieved record sales.

Via Chartmill

Topics Earnings

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.